Invivofectamine™ 3.0 试剂
Invivofectamine™ 3.0 试剂
Invitrogen™

Invivofectamine™ 3.0 试剂

Invivofectamine™ 3.0 试剂是一种非动物源性脂质纳米微粒,设计用于在尾静脉注射后将 siRNA 和 miRNA 高效体内递送至小鼠活细胞。使用 Invivofectamine™ 3.0了解更多信息
Have Questions?
更改视图buttonViewtableView
货号反应次数
IVF300110
IVF300550 次反应
货号 IVF3001
价格(CNY)
24,420.00
Each
添加至购物车
反应次数:
10
价格(CNY)
24,420.00
Each
添加至购物车
Invivofectamine™ 3.0 试剂是一种非动物源性脂质纳米微粒,设计用于在尾静脉注射后将 siRNA 和 miRNA 高效体内递送至小鼠活细胞。

使用 Invivofectamine™ 3.0 试剂
Invivofectamine™ 3.0 试剂是体内递送 siRNA 和 miRNA 双链体的理想选择。使用低体积、低压力法递送 Invivofectamine™ 3.0/RNA 复合物,对动物无毒性、无应激反应。Invivofectamine™ 3.0 还可与 BLOCK-iT™ 荧光对照品结合,以跟踪 siRNA 或 miRNA 的生物分布。
仅供科研使用。不可用于诊断程序。
规格
分类无动物来源
适用于(应用)转染
反应次数10
产品线Invivofectamine™
产品类型试剂名称
数量10 reactions
RNAi 类型siRNA、miRNA
血清兼容性
运输条件干冰
细胞类型肝细胞
样品类型合成 siRNA, siRNA, miRNA, RNAi
种属小动物模型
转染技术脂质体转染、脂质体纳米微粒、LNP
Unit SizeEach

常见问题解答 (FAQ)

How do I isolate RNA from liver or other organs for my in vivo siRNA experiment?

Isolating high-quality RNA is critical to the overall success of in vivo experiments.

What rate should I use to inject complexed material for a systemic injection for my in vivo siRNA experiment?

Invivofectamine 3.0 Reagent is designed to be delivered slowly and evenly; a 200-µL injection should take between 10 to 20 seconds.

How important is sterile technique for my in vivo siRNA experiment?

Sterile technique is vital to successful completion of in vivo experiments. All materials need to be sterile before injecting the complexed siRNA into animals.

Can I modify the encapsulation protocol to fit my schedule for my in vivo siRNA experiment?

The protocol is robust but specific. Protocol modifications will likely result in less than optimal performance.

What controls should I use for my in vivo siRNA experiment?

Both positive and negative controls are recommended when performing any siRNA experiment. We typically use Invitrogen in vivo siRNA against Factor VII with Invivofectamine 3.0 Reagent, as a positive control for experiments. It is also good practice to use PBS solution as a negative control.